FDA Designates Two Rapid Tests as Breakthrough Devices in Fight Against Antimicrobial Resistance The FDA has granted Breakthrough Device Designation to NG Biotech's rapid tests targeting critical antibiotic-resistant pathogens, aiding in urgent health needs.

FDA Designates Two Rapid Tests as Breakthrough Devices in Fight Against Antimicrobial Resistance #USA #Antimicrobial_Resistance #Hardy_Diagnostics #NG_Biotech #Guipry

FDA Grants Breakthrough Designation to Two Rapid Tests for Drug-Resistant Pathogens NG Biotech's collaboration with Hardy Diagnostics leads to FDA's designation of two rapid tests as breakthrough devices, aiming to combat antimicrobial resistance effectively.

FDA Grants Breakthrough Designation to Two Rapid Tests for Drug-Resistant Pathogens #USA #AMR #Santa_Maria #Hardy_Diagnostics #NG_Biotech

FDA Approves Innovations in Rapid Testing for Drug-Resistant Pathogens NG Biotech and Hardy Diagnostics unveil rapid tests for critical drug-resistant pathogens, now recognized by the FDA as breakthrough devices.

FDA Approves Innovations in Rapid Testing for Drug-Resistant Pathogens #USA #Antimicrobial_Resistance #Santa_Maria #Hardy_Diagnostics #NG_Biotech

FDA Grants Innovative Device Designation for Two Rapid Tests Targeting Drug-Resistant Pathogens In a breakthrough against antimicrobial resistance, the FDA has designated two rapid tests developed by NG Biotech and Hardy Diagnostics as innovative devices.

FDA Grants Innovative Device Designation for Two Rapid Tests Targeting Drug-Resistant Pathogens #USA #Antimicrobial_Resistance #Santa_Maria #Hardy_Diagnostics #NG_Biotech

Hardy Diagnostics and NEMIS Technologies Team Up for Pathogen Detection Innovation in North America Hardy Diagnostics partners with NEMIS Technologies to introduce rapid on-site pathogen detection technology to the North American market, enhancing food safety.

Hardy Diagnostics and NEMIS Technologies Team Up for Pathogen Detection Innovation in North America #United_States #Santa_Maria #Hardy_Diagnostics #NEMIS_Technologies #N-Light_technology

Hardy Diagnostics Announces Leadership Transition with New CEO Christopher Catani Hardy Diagnostics has officially announced the retirement of its founder and CEO Jay Hardy, appointing Christopher Catani as the new CEO. This marks a significant leadership change at the company, effective immediately.

Hardy Diagnostics Announces Leadership Transition with New CEO Christopher Catani #United_States #Santa_Maria,_California #Hardy_Diagnostics #Jay_Hardy #Christopher_Catani

New FDA-Cleared Rapid Test to Detect CTX-M Enzymes Revolutionizes Microbiology Labs The newly FDA-cleared NG-TEST® CTX-M Multi by Hardy Diagnostics offers a fast and effective solution for detecting CTX-M enzymes, crucial for managing antibiotic resistance effectively.

New FDA-Cleared Rapid Test to Detect CTX-M Enzymes Revolutionizes Microbiology Labs #United_States #Santa_Maria #Hardy_Diagnostics #NG-TEST #CTX-M_Enzymes